Validating the Safety & Efficacy of Antigen Specific Immune Tolerance Therapies Using In Vitro & In Vivo Assays
Time: 2:00 pm
day: Custom Day Two
Details:
• Evaluating the ability of APCs to present the target antigen to T-cells
• Discussing the advantages and disadvantages of animal models to study the autoimmune diseases
• Establishing a correlation between in vitro and in vivo findings to identify consistent trends and patterns to validate the efficacy
